The Strategic Role of the Clinical Pharmacist in Oncology: Medication Reconciliation, Active Pharmacovigilance, and Safety in Antineoplastic Handling
The Strategic Role of the Clinical Pharmacist in Oncology: Medication Reconciliation, Active Pharmacovigilance, and Safety in Antineoplastic Handling
DOI:
https://doi.org/10.51473/rcmos.v1i2.2024.2078Keywords:
Oncology. Clinical Pharmacy. Patient Safety. Antineoplastic Handling. Pharmacovigilance. Medication Reconciliation.Abstract
This scientific article examines the multifaceted role of the clinical pharmacist in oncology patient care, ranging from technical safety in antineoplastic handling to direct clinical interventions such as medication reconciliation and pharmacovigilance. The research is grounded in current regulatory standards, specifically ANVISA's RDC 220/2004, and international guidelines from ASCO and NCCN to discuss the prevention of medication errors and toxicity management. The importance of integrating the pharmacist into the multidisciplinary team, as advocated by Hepler and Strand's concepts of Pharmaceutical Care, is analyzed for pharmacotherapy optimization. The conclusion highlights the positive impact of these actions on survival, treatment adherence, and quality of life for oncology patients.
Downloads
References
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA (Brasil). Resolução RDC nº 220, de 21 de setembro de 2004. Aprova o Regulamento Técnico de funcionamento dos Serviços de Terapia Antineoplásica. Brasília: ANVISA, 2004.
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA (Brasil). Resolução RDC nº 222, de 28 de março de 2018. Regulamenta as Boas Práticas de Gerenciamento dos Resíduos de Serviços de Saúde e dá outras providências. Brasília: ANVISA, 2018.
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA (Brasil). Resolução RDC nº 430, de 8 de outubro de 2020. Dispõe sobre as Boas Práticas de Distribuição, Armazenagem e de Transporte de Medicamentos. Brasília: ANVISA, 2020.
AMERICAN SOCIETY OF CLINICAL ONCOLOGY. Chemotherapy administration safety standards. Journal of Clinical Oncology, v. 37, 2019.
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS. ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, Bethesda, 2018.
BATES, D. W. et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA, v. 280, n. 15, p. 1311-1316, 1998. DOI: https://doi.org/10.1001/jama.280.15.1311
BONASSA, E. M. A.; GATO, M. I. R. Terapêutica oncológica para enfermeiros e farmacêuticos. 4. ed. São Paulo: Atheneu, 2012.
BRASIL. Ministério da Saúde. HumanizaSUS: documento base para gestores e trabalhadores do SUS. 4. ed. Brasília: Ministério da Saúde, 2010.
BRASIL. Ministério do Trabalho e Emprego. Norma Regulamentadora nº 32 (NR-32): segurança e saúde no trabalho em serviços de saúde. Brasília: MTE, 2019.
CONSELHO FEDERAL DE FARMÁCIA. Resolução nº 585, de 29 de agosto de 2013. Regulamenta as atribuições clínicas do farmacêutico e dá outras providências. Brasília: CFF, 2013.
CORNISH, P. L. et al. Unintended medication discrepancies at the time of hospital admission. Archives of Internal Medicine, v. 165, n. 4, p. 424-429, 2005. DOI: https://doi.org/10.1001/archinte.165.4.424
HEPLER, C. D.; STRAND, L. M. Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, v. 47, n. 3, p. 533-543, 1990. DOI: https://doi.org/10.1093/ajhp/47.3.533
INSTITUTE FOR HEALTHCARE IMPROVEMENT. ISMP Medication Safety Self Assessment® for Oncology. Horsham: ISMP, 2012.
JOINT COMMISSION INTERNATIONAL. Padrões de acreditação da Joint Commission International para hospitais. 5. ed. Rio de Janeiro: CBA, 2014.
NATIONAL COMPREHENSIVE CANCER NETWORK. NCCN clinical practice guidelines in oncology: antiemesis. Version 2.2020. Plymouth Meeting: NCCN, 2020.
NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings. Cincinnati: CDC/NIOSH, 2016.
SCOTT, I. A. et al. Minimizing inappropriate medications in older populations: a 10-step conceptual framework. American Journal of Medicine, v. 128, n. 3, p. 251-262, 2015.
SOBOLL, M. L. M. S. et al. Riscos ocupacionais em oncologia: uma revisão integrativa. Revista Brasileira de Medicina do Trabalho, v. 13, n. 1, 2015.
TRISSEL, L. A. Handbook on injectable drugs. 21. ed. Bethesda: American Society of Health-System Pharmacists, 2021.
WORLD HEALTH ORGANIZATION. The High 5s Project: standard operating protocols – medication reconciliation. Geneva: WHO, 2014.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2024 Juliana de Moura Lima Silva (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This means you are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The use of this material is conditioned upon proper attribution to the original author(s), providing a link to the license, and indicating if changes were made. The license does not require permission from the author or the publisher as long as these conditions are met.
The Creative Commons license logo is displayed permanently in the footer of the journal.
The copyright of the manuscript can be retained by the authors without restrictions and can be requested at any time, even after publication in the journal.
How to Cite
